| ORD | optical rotatory dispersion; oral radiation death |
|---|---|
| PDSG | pigment dispersion syndrome glaucoma |
| HBsAg/adr | hepatitis B surface antigen manifesting group-specific determinant a and subtype-specific determinan... |
| LSP | left sacroposterior [fetal position]; linguistic string project; liver-specific protein; lymphocyte-... |
| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
| london dispersion forces | <chemistry> The forces that exist in nonpolar molecules that involve an accidental dipole that induces a momentary dipole in a neighbor. (09 Jan 1998) |
|---|---|
| age-specific rate | A rate for a specified age group, in which the numerator and denominator refer to the same age group. (05 Mar 2000) |
| Bensley's specific granules | Granule's in the cells of the islands of Langerhans in the pancreas. (05 Mar 2000) |
| brain-specific kinase | <enzyme> Expressed specifically in brain; member of the eph/elk receptor-like kinase family; mw 105 kD; may represent murine homolog of chicken cek7 receptor-like kinase; amino acid sequence given in first source Registry number: EC 2.7.1.- Synonym: bsk tyrosine kinase (26 Jun 1999) |
| galactosyl-1-3-N-acetylgalactosaminyl-specific 2,6-sialyltransferase | <enzyme> Genbank x77775 Registry number: EC 2.4.99.- Synonym: galbeta1,3galnac 2,6-sialyltransferase, st6galnac II (26 Jun 1999) |
| glycoprotein hormone-specific N-acetylgalactosamine transferase | <enzyme> Transfers galnac to the terminal glcnac moieties of glcnac2man3glcnac2asn Registry number: EC 2.4.1.- Synonym: ghs-acgalnh2 transferase, glycoprotein hormone galnac transferase, glycoprotein hormone - n-acetylgalactosaminyltransferase (26 Jun 1999) |
| retina-specific amine oxidase | <enzyme> Genbank d88213 Registry number: EC 1.4.- Synonym: rao enzyme, human (26 Jun 1999) |
| Gomori's non-specific acid phosphatase stain | <technique> A method in which formalin-fixed frozen sections are incubated in a substrate containing sodium beta-glycerophosphate and lead nitrate at pH 5.0; the insoluble lead phosphate produced is treated with ammonium sulfide to give a black lead sulfide. (05 Mar 2000) |
| Gomori's non-specific alkaline phosphatase stain | <technique> A calcium-cobalt sulfide method using frozen sections or cold acetone-or formalin-fixed paraffin sections, plus sodium beta-glycerophosphate as a substrate at pH 9.0 to 9.5 with Mg++ as activator; calcium ions precipitate the liberated phosphate, cobalt salt replaces the calcium phosphate, and ammonium sulfide converts the product to a black cobalt sulfide. (05 Mar 2000) |
| group-specific protease | <enzyme> A serine protease, obtained from rat small intestine, which preferentially inactivates the apo forms of certain pyridoxal phosphate requiring enzymes Registry number: EC 3.4.21.- (26 Jun 1999) |
| RNA, transfer, amino acid-specific | A group of transfer rnas which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis. (12 Dec 1998) |
| poly A specific exoribonuclease | <enzyme> Acts on 2' or 3'-linked oligoriboadenylates to liberate 5'-AMP Registry number: EC 3.1.13.- Synonym: 2',3'-exoribonuclease, 3'-exoribonuclease (26 Jun 1999) |
| poly(A)-specific ribonuclease | <enzyme> From vigna unguiculata seedlings; bifunctional enzyme responsible for both poly(a)-polymerizing and poly(a)-hydrolyzing activities; removes the poly(a) tail as the first step in degrading mRNA Registry number: EC 3.1.13.4 Synonym: poly(a) nuclease, mRNA poly(a) nuclease, poly(a) ribonuclease (pan), pan2 protein (26 Jun 1999) |
| myelencephalon-specific serine protease | <enzyme> Specifically expressed in the nervous system; plays a role in normal homeostasis and response of spinal cord to injury. Registry number: EC 3.4.21.- Synonym: myelencephalon-specific protease, msp enzyme (26 Jun 1999) |
| pregnancy-specific beta 1-glycoprotein | A glycoprotein with the electrophoretic mobility of a beta-1 globulin. It is produced by the placental trophoblast and secreted into the maternal bloodstream during pregnancy. It can be detected 18 days after ovulation and its concentration in plasma rises steadily until, at the end of gestation, it reaches 200 mg/ml. It has been proposed as a measure of placental function for fertility control and is a candidate for an early pregnancy test. (12 Dec 1998) |